These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 6137424

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Tocolysis and its place in premature labor].
    Stoĭkov S, Popov I.
    Akush Ginekol (Sofiia); 1999; 38(1):11-3. PubMed ID: 11965710
    [Abstract] [Full Text] [Related]

  • 26. [Beta-mimetic agents in obstetric prophylaxis].
    Balbi F, Donini G.
    Minerva Ginecol; 1978; 30(1-2):77-85. PubMed ID: 25398
    [No Abstract] [Full Text] [Related]

  • 27. [Fetal hydrops following indomethacin administration during pregnancy].
    Verboom AJ, de Leeuw R.
    Ned Tijdschr Geneeskd; 1983 Jan 01; 127(1):18-20. PubMed ID: 6828168
    [No Abstract] [Full Text] [Related]

  • 28. [Prevention of premature labor].
    Ruckhäberle KE.
    Zentralbl Gynakol; 1986 Jan 01; 108(5):265-76. PubMed ID: 2871675
    [Abstract] [Full Text] [Related]

  • 29. The treatment of threatened premature labor by tocolytics, Ca++-Antagonists and anti-inflammatory drugs.
    Mosler KH.
    Arzneimittelforschung; 1975 Feb 01; 25(2):263-6. PubMed ID: 235269
    [Abstract] [Full Text] [Related]

  • 30. [Inhibition of labour. Symposium by letter (author's transl)].
    Hüter J, Baumgarten K, Jung H, Melchior J, Mosler KH, Weidinger H.
    Geburtshilfe Frauenheilkd; 1974 Sep 01; 34(9):689-98. PubMed ID: 4155045
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pharmacotherapy of preterm labor.
    Travis BE, McCullough JM.
    Pharmacotherapy; 1993 Sep 01; 13(1):28-36. PubMed ID: 8437965
    [Abstract] [Full Text] [Related]

  • 33. [Good sense and nonsense in tocolysis].
    Husslein P, Reisenberger K, Leitich C.
    Zentralbl Gynakol; 1995 Sep 01; 117(6):300-3. PubMed ID: 7645357
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Possibilities and limitations of uterine contraction inhibiting agents].
    Eskes TK.
    Ned Tijdschr Geneeskd; 1976 Jan 10; 120(2):61-7. PubMed ID: 2884
    [No Abstract] [Full Text] [Related]

  • 36. [Prevention of premature labor].
    Béguin F.
    Gynakol Rundsch; 1975 Jan 10; 15 suppl 1():18-26. PubMed ID: 5344
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Pathogenetic treatment with tocolytic drugs of pregnant women with threatened premature labor].
    Murashko LE, Karibaeva BZh.
    Akush Ginekol (Mosk); 1987 Oct 10; (10):30-4. PubMed ID: 2893558
    [No Abstract] [Full Text] [Related]

  • 39. [Maternal complications of the treatment of threatened premature labor].
    Thoulon JM, Domenichini Y, Beaune J.
    Rev Prat; 1984 Dec 21; 34(59):3315-9. PubMed ID: 6151740
    [No Abstract] [Full Text] [Related]

  • 40. [Treatment of intra-partum fetal distress. I. Use of beta-mimetic drugs. Orciprenaline].
    Vargas García C, Lowenberg E.
    Ginecol Obstet Mex; 1980 Oct 21; 48(288):231-45. PubMed ID: 7215898
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.